InvestorsHub Logo
Followers 4
Posts 332
Boards Moderated 0
Alias Born 12/22/2014

Re: None

Monday, 05/27/2019 3:33:30 PM

Monday, May 27, 2019 3:33:30 PM

Post# of 20689
MNTA / CFIUS, article / paragraph why a deal failed

Momenta Pharmaceuticals, a Boston-area biotech, experienced the collapse of a proposed spinout of part of its business to a syndicate of China-based investors over concerns about CFIUS, said CEO Craig Wheeler, leading to the company’s September, 2018, partial shutdown. The impact: 110 lost jobs.



see https://www.forbes.com/sites/stevedickman/2019/05/24/us-crackdown-on-foreign-biotech-investment-makes-us-poorer-not-safer/#2976510e5581